Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

C-Further Unveils First Therapeutic Programmes Dedicated to Paediatric Oncology

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Research
Philanthropy
Biotechnology
Fund Raising
Pharmaceutical
Health
Foundation
Other Philanthropy
Science
Oncology
C-Further

More Like This

Business Wire logo

C-Further announces major partnership with GOSH Charity to drive innovation in childhood cancer treatment

XNK Therapeutics receives funding from Sweden's innovation agency Vinnova

Business Wire logo

Incyte Announces More than 50 Abstracts Accepted for Presentation at the 2025 ASH Annual Meeting

Business Wire logo

Incyte Announces More Than 20 Abstracts Accepted for Presentation at the European Hematology Association (EHA) 2026 Congress

Business Wire logo

Transition Bio Partners with the Little Warrior Foundation

UCSF Benioff Children's Hospitals Become the First US Qualified Treatment Center Contracted to Administer Individualized Gene Therapy WASKYRA®

SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN

Mestag Therapeutics Awarded Significant Grant from Innovate UK’s Prestigious Cancer Therapeutics Program to Accelerate the Path to the Clinic for MST-0300

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us